Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K KRAMER

Showing results (521-530 of 621) with videos related to

Pageof 63
Sort By:
Scandinavian Journal of Pain|June 19, 2026
Multimodal investigation of neuropathic pain mechanisms in focal spinal lesionsPaulina S Scheuren, Gergely David, John L K Kramer, et al.
European Journal of Clinical Pharmacology|September 29, 1999
Absorption, metabolism and excretion of a single oral dose of (14)C-repaglinide during repaglinide multiple dosingP N van Heiningen, V Hatorp, K Kramer Nielsen, et al.
Cell Reports|February 16, 2017
Early Administration of Gabapentinoids Improves Motor Recovery after Human Spinal Cord InjuryFreda M Warner, Jacquelyn J Cragg, Catherine R Jutzeler, et al.
Diabetes, Obesity & Metabolism|May 6, 2021
Short-term intensive insulin as induction and maintenance therapy for the preservation of beta-cell function in early type 2 diabetes (RESET-IT Main): A 2-year randomized controlled trialRavi Retnakaran, Alexandra Emery, Chang Ye, et al.
Pain|November 21, 2015
Meta-analysis of placebo responses in central neuropathic pain: impact of subject, study, and pain characteristicsJacquelyn J Cragg, Freda M Warner, Nanna Brix Finnerup, et al.
NPJ Digital Medicine|July 22, 2025
Modeling trajectories of routine blood tests as dynamic biomarkers for outcome in spinal cord injuryMarzieh Mussavi Rizi, Daniel Fernández, John L K Kramer, et al.
Topics in Spinal Cord Injury Rehabilitation|December 15, 2012
Outcome Measures for Acute/Subacute Cervical Sensorimotor Complete (AIS-A) Spinal Cord Injury During a Phase 2 Clinical TrialJohn D Steeves, Daniel P Lammertse, John L K Kramer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicinS A van Acker, E Boven, K Kuiper, et al.
Magnetic Resonance in Medicine|September 7, 2021
A data-driven T<sub>2</sub> relaxation analysis approach for myelin water imaging: Spectrum analysis for multiple exponentials via experimental condition oriented simulation (SAME-ECOS)Hanwen Liu, Tigris S Joseph, Qing-San Xiang, et al.
Medical and Pediatric Oncology|December 7, 2000
Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8K Kramer, N K Cheung, J L Humm, et al.
Pageof 63

Showing results (521-530 of 621) with videos related to

Sort By:
Pageof 63
Scandinavian Journal of Pain|June 19, 2026
Multimodal investigation of neuropathic pain mechanisms in focal spinal lesionsPaulina S Scheuren, Gergely David, John L K Kramer, et al.
European Journal of Clinical Pharmacology|September 29, 1999
Absorption, metabolism and excretion of a single oral dose of (14)C-repaglinide during repaglinide multiple dosingP N van Heiningen, V Hatorp, K Kramer Nielsen, et al.
Cell Reports|February 16, 2017
Early Administration of Gabapentinoids Improves Motor Recovery after Human Spinal Cord InjuryFreda M Warner, Jacquelyn J Cragg, Catherine R Jutzeler, et al.
Diabetes, Obesity & Metabolism|May 6, 2021
Short-term intensive insulin as induction and maintenance therapy for the preservation of beta-cell function in early type 2 diabetes (RESET-IT Main): A 2-year randomized controlled trialRavi Retnakaran, Alexandra Emery, Chang Ye, et al.
Pain|November 21, 2015
Meta-analysis of placebo responses in central neuropathic pain: impact of subject, study, and pain characteristicsJacquelyn J Cragg, Freda M Warner, Nanna Brix Finnerup, et al.
NPJ Digital Medicine|July 22, 2025
Modeling trajectories of routine blood tests as dynamic biomarkers for outcome in spinal cord injuryMarzieh Mussavi Rizi, Daniel Fernández, John L K Kramer, et al.
Topics in Spinal Cord Injury Rehabilitation|December 15, 2012
Outcome Measures for Acute/Subacute Cervical Sensorimotor Complete (AIS-A) Spinal Cord Injury During a Phase 2 Clinical TrialJohn D Steeves, Daniel P Lammertse, John L K Kramer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicinS A van Acker, E Boven, K Kuiper, et al.
Magnetic Resonance in Medicine|September 7, 2021
A data-driven T<sub>2</sub> relaxation analysis approach for myelin water imaging: Spectrum analysis for multiple exponentials via experimental condition oriented simulation (SAME-ECOS)Hanwen Liu, Tigris S Joseph, Qing-San Xiang, et al.
Medical and Pediatric Oncology|December 7, 2000
Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8K Kramer, N K Cheung, J L Humm, et al.
Pageof 63